Skip to content

Clinical trials

Phase 2 Epilepsy trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Epilepsy Phase: Phase 2 Country / region: Germany Clear all

17 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20031
20051
20061
20071
20082
20092
20111
20182
20193
20242

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed12
Active, not recruiting2
Terminated2
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
UCB Pharma3
Eisai Inc.2
UCB Biopharma S.P.R.L.2
Addex Pharma S.A.1
Bial - Portela C S.A.1
Biohaven Therapeutics Ltd.1
Children's University Hospital Cologne, Germany1
Eisai Co., Ltd.1
Novartis1
UCB BIOSCIENCES, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Epilepsy17
Seizures6
Epilepsies, Partial3
Drug Resistant Epilepsy2
Dystonia1
Learning Disabilities1
Migraine Disorders1

Trials

Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.